{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:03:28Z","timestamp":1771956208407,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jneuroim.2007.12.007","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T15:15:48Z","timestamp":1204557348000},"page":"116-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["IFN-\u03b2-regulated genes show abnormal expression in therapy-na\u00efve relapsing\u2013remitting MS mononuclear cells: Gene expression analysis employing all reported protein\u2013protein interactions"],"prefix":"10.1016","volume":"195","author":[{"given":"Ken D.","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Croze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Charis","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharlene","family":"Velichko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Reder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.12.007_bib1","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1999"},{"key":"10.1016\/j.jneuroim.2007.12.007_bib2","doi-asserted-by":"crossref","first-page":"15278","DOI":"10.1073\/pnas.0507477102","article-title":"Application of a priori established gene sets to discover biologically important differential expression in microarray data","volume":"102","author":"Bild","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/bioinformatics\/btg410","article-title":"A benchmark for Affymetrix GeneChip expression values","volume":"20","author":"Cope","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jneuroim.2007.12.007_bib4","first-page":"S215","article-title":"Betaseron in multiple sclerosis: peripheral blood mononuclear cell gene expression profiles on multiple sclerosis patients suggest multiple mechanisms of action and potential biomarkers","volume":"10","author":"Croze","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib5","series-title":"Statistical Methods for Research Workers","author":"Fisher","year":"1936"},{"key":"10.1016\/j.jneuroim.2007.12.007_bib6","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng2103","article-title":"Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis","volume":"39","author":"Gregory","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.1970.tb01436.x","article-title":"Tissue typing using a routine one-step lymphocyte separation technique","volume":"18","author":"Harris","year":"1970","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","article-title":"Interferon beta-1b is effective in relapsing\u2013remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"43","author":"The IFN beta Multiple Sclerosis Study Group","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.12.007_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"The International Multiple Sclerosis Genetics Consortium","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib11","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.12.007_bib13","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ng2106","article-title":"Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis","volume":"39","author":"Lundmark","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nbt965","article-title":"Microarray reality checks in the context of a complex disease","volume":"22","author":"Miklos","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib16","first-page":"S112","article-title":"Betaseron pharmacogenomics studies: gene expression profiling in healthy individuals and relapsing\u2013remitting multiple sclerosis patients after a single dose of Betaseron","volume":"11","author":"Velichko","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib17","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.4049\/jimmunol.171.5.2694","article-title":"Genomic effects of IFN-\u03b2 in multiple sclerosis patients","volume":"171","author":"Weinstock-Guttman","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.12.007_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2105-7-171","article-title":"Automatic pathway building in biological association networks","volume":"7","author":"Yuryev","year":"2006","journal-title":"BMC Bioinformatics"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:09:05Z","timestamp":1759046945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0165572807004456"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.12.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03b2-regulated genes show abnormal expression in therapy-na\u00efve relapsing\u2013remitting MS mononuclear cells: Gene expression analysis employing all reported protein\u2013protein interactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}